The appearance is White to light yellow crystalline powder, CAS number is 66309-69-1, and the molecular formula is c18h23n9o4s3.hcl.
Market Analysis and Insights: Global Cefotiam Hydrochloride API Market
Due to the COVID-19 pandemic, the global Cefotiam Hydrochloride API market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, Purity ≥ 97 % accounting for % of the Cefotiam Hydrochloride API global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Cefotiam Hydrochloride Injection segment is altered to an % CAGR throughout this forecast period.
North America Cefotiam Hydrochloride API market is estimated at US$ million in 2021, while Europe is forecast to reach US$ million by 2028. The proportion of the North America is % in 2021, while Europe percentage is %, and it is predicted that Europe share will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. As for the Asia, the notable markets are Japan and South Korea, CAGR is % and % respectively for the next 6-year period.
The global major manufacturers of Cefotiam Hydrochloride API include Daewoong Bio, Harbin Pharmaceutical Group, Qilu Pharmaceutial, Orchid Pharma, Yungjin Pharm, SPC Pharma, Luoxin Pharmaceutical, Zhejiang Yongning Pharmaceutical and Chongqing Shenghuaxi Pharma, etc. In terms of revenue, the global 3 largest players have a % market share of Cefotiam Hydrochloride API in 2021.
Global Cefotiam Hydrochloride API Market: Drivers and Restrains
The research report has incorporated the analysis of different factors that augment the market’s growth. It constitutes trends, restraints, and drivers that transform the market in either a positive or negative manner. This section also provides the scope of different segments and applications that can potentially influence the market in the future. The detailed information is based on current trends and historic milestones. This section also provides an analysis of the volume of production about the global market and about each type from 2017 to 2028. This section mentions the volume of production by region from 2017 to 2028. Pricing analysis is included in the report according to each type from the year 2017 to 2028, manufacturer from 2017 to 2022, region from 2017 to 2022, and global price from 2017 to 2028.
A thorough evaluation of the restrains included in the report portrays the contrast to drivers and gives room for strategic planning. Factors that overshadow the market growth are pivotal as they can be understood to devise different bends for getting hold of the lucrative opportunities that are present in the ever-growing market. Additionally, insights into market expert’s opinions have been taken to understand the market better.
Global Cefotiam Hydrochloride API Market: Segment Analysis
The research report includes specific segments by region (country), by manufacturers, by Type and by Application. Each type provides information about the production during the forecast period of 2017 to 2028. by Application segment also provides consumption during the forecast period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
Purity ≥ 97 %
Purity ≥ 98 %
Purity ≥ 99 %
Segment by Application
Cefotiam Hydrochloride Injection
Other
By Company
Daewoong Bio
Harbin Pharmaceutical Group
Qilu Pharmaceutial
Orchid Pharma
Yungjin Pharm
SPC Pharma
Luoxin Pharmaceutical
Zhejiang Yongning Pharmaceutical
Chongqing Shenghuaxi Pharma
Syntech Pharmachem
KyungDong Pharma
Tianjin GreenPine Pharma
Nanjing Chemlin Chemical Indusstry
Production by Region
North America
Europe
China
Japan
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina